All G Adds Malaysian Life Sciences Investor Xeraya Capital to Pre-Series B Round

Australian precision fermentation company All G has added Malaysian life sciences investor Xeraya Capital to its pre-Series B round, giving the company access to the Southeast Asian nutrition and infant formula markets. Xeraya joins existing backers in supporting All G's production of animal-free lactoferrin and other milk proteins through precision fermentation. This investment is seen as a significant endorsement of All G's scientific direction and commercial potential in the region.

Xeraya's interest in food security and functional proteins aligns well with All G's focus on lactoferrin, a milk protein known for its iron-regulating and immune-supporting properties. The firm's investment in All G is based on the scalability of its fermentation platform and the potential to improve nutrition and health outcomes, particularly in fast-growing Southeast Asian markets. All G sees this partnership as opening up new commercialization opportunities in the region's nutrition markets, with Xeraya's connections expected to accelerate access to these opportunities.